Clinical Trials

Phase EARLY_PHASE1 Not yet recruiting

Colonic Neoplasms

NCT07318389 2026-02-27

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

100 enrolled

Colorectal Neoplasms

NCT04587128 2026-02-05

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

34 enrolled

Colorectal Neoplasms

NCT06268015 2026-02-05

BBOpCo

16 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT04787341 2026-02-02

PARERE

214 enrolled

Colorectal Neoplasms

NCT03087071 2026-01-12

Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer

59 enrolled

Colorectal Neoplasms

NCT03983993 2026-01-05

NIPAVect

26 enrolled 8 charts

Colorectal Neoplasms

NCT06332079 2026-01-05

HAITI

Phase 2 Terminated

4 enrolled

Colorectal Cancer Metastatic

NCT06714357 2025-12-17

VICTORIA

130 enrolled

Colorectal Neoplasms

NCT06245356 2025-12-10

TRIFLUOX-DP

73 enrolled

Colorectal Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

NCT05576896 2025-10-20

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

43 enrolled

Colorectal Neoplasms

NCT01312857 2025-10-09

Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer

75 enrolled 12 charts

Colorectal Neoplasms

NCT06490536 2025-08-29

The Sagittarius Trial

Phase 3 Recruiting

700 enrolled

Colonic Neoplasms

NCT02885753 2025-07-09

OSCAR

Phase 3 Recruiting

348 enrolled

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT03442569 2025-07-01

PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC

56 enrolled 13 charts

Colonic Neoplasms

NCT03186326 2025-06-29

SAMCO

132 enrolled

Colorectal Neoplasms

NCT03584711 2025-06-29

OPTIPRIME

118 enrolled

Colorectal Neoplasms

NCT06978400 2025-05-18

A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer

64 enrolled

Neoplasms, Colorectal Neoplasms

NCT03428958 2025-04-23

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

Phase 1/2 Completed

111 enrolled 22 charts

Colonic Neoplasms, Colorectal Neoplasms

NCT02162563 2025-02-06

CAIRO5

Phase 3 Completed

530 enrolled

Colorectal Neoplasms

NCT01814501 2025-02-05

Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

16 enrolled 11 charts

Phase 1/2 Active not recruiting

Colonic Neoplasms, Rectal Neoplasms

NCT05121038 2024-12-17

CENDIFOX

50 enrolled

Phase 3 Active not recruiting

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms

NCT03635021 2024-10-21

CR-SEQUENCE

419 enrolled

Colorectal Neoplasms

NCT03164655 2024-10-01

SULTAN

20 enrolled

Colorectal Cancer Metastatic

NCT04117945 2024-09-27

Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer

22 enrolled 17 charts

Colorectal Neoplasms

NCT03263429 2024-08-30

Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer

Phase 1/2 Completed

29 enrolled 17 charts

Colorectal Neoplasms

NCT06575127 2024-08-28

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

60 enrolled

Colonic Neoplasms, Neoplasms

NCT06509126 2024-07-19

IMPROVE-2

Phase 3 Recruiting

500 enrolled

Colorectal Neoplasms

NCT03992456 2024-05-21

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

12 enrolled 16 charts

Phase 3 Active not recruiting

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01910610 2024-03-12

STRATEGIC-1

464 enrolled

Colorectal Cancer Metastatic

NCT05468892 2024-02-01

VELO

68 enrolled

Colonic Neoplasms

NCT01307956 2023-10-26

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

Phase 2 Terminated

11 enrolled 11 charts

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT01328171 2023-06-15

VOLFI

93 enrolled

Colorectal Neoplasms

NCT01991873 2023-06-15

PanaMa

387 enrolled

Colorectal Neoplasms

NCT01801904 2023-03-24

PACER

Phase 2 Unknown

52 enrolled

Colorectal Neoplasms

NCT03231722 2023-01-05

TRIPLETE

Phase 3 Completed

435 enrolled

Colorectal Neoplasms

NCT03227926 2022-08-25

CHRONOS

32 enrolled

Colorectal Neoplasms

NCT00389870 2022-06-01

Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil

Phase 3 Completed

1,198 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02399943 2022-05-16

A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer

14 enrolled

Colorectal Neoplasms

NCT04425239 2022-04-07

IMPROVE

151 enrolled

Colorectal Neoplasms

NCT03000374 2022-03-17

PIER

34 enrolled

Rectal Neoplasms

NCT03751176 2021-06-30

BEYOND

Phase 2 Unknown

31 enrolled

Colorectal Cancer Metastatic

NCT03142516 2021-06-21

OPALO

20 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT03311750 2021-06-07

A-REPEAT

Phase 2 Terminated

23 enrolled

Advanced Colorectal Cancer

NCT01077999 2021-04-21

Chemoradiation and Panitumumab for Esophageal Cancer

78 enrolled

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT02015923 2021-03-16

CCRe-IV

Phase 4 Terminated

107 enrolled

Colonic Neoplasms, Neoplasm Metastasis

NCT02008383 2021-02-12

CaboMAb

Phase 1 Completed

29 enrolled

Colorectal Neoplasms

NCT04668976 2020-12-21

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Phase 2 Unknown

100 enrolled

Colorectal Neoplasms, Cholangiocarcinoma

NCT01443065 2020-11-17

MEGA

162 enrolled